US Clinical Chemistry and Immunodiagnostics Markets Future Reviewed in New Report Published at MarketPublishers.com

06 Dec 2011 • by Natalie Aster
US Clinical Chemistry and Immunodiagnostics Markets Future Reviewed in New Report Published at MarketPublishers.com

LONDON – Forecasts say the world clinical chemistry and immunodiagnostics markets will undergo significant changes over the nest decade. The grounds for this transformation lie in the progressive development of immunodiagnostic technologies, system engineering, automation, and IT. Convergence of new and more regulations combined with competitive expansion can also be considered as major growth contributors. This developing marketplace is poised for creating dramatic opportunities for a range of new instruments, reagent systems, and auxiliary products like specimen preparation devices, controls, calibrators, and many more.

New market research report “Future US Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies” prepared by Venture Planning Group has been recently published at Market Publishers Ltd.

Report Details:

Title: Future US Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies
Published: November, 2011
Pages: 600
Price: US$ 10,700

The report delves into a comprehensive analysis of the US clinical chemistry and immunodiagnostics markets, including:

  • major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends;
  • five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays;
  • five- and ten-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens;
  • five- and ten-year reagent and instrument sales forecasts;
  • review of current instrumentation technologies, and a feature comparison of 50 high, medium-, and low-volume/POC analyzers;
  • sales and market shares of leading reagent and instrument suppliers;
  • review of current and emerging technologies and their potential market applications;
  • product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables;
  • profiles of 25 current and emerging suppliers;
  • market penetration strategies, entry barriers and risks.

Reports Contents:

Introduction

Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
  1. Albumin
  2. Alkaline Phosphatase
  3. ALT/SGPT
  4. Ammonia
  5. Amylase
  6. AST/SGOT
  7. Bilirubin
  8. Blood Gases
  9. Blood Urea Nitrogen (BUN)
  10. Calcium
  11. Cholesterol
  12. Cholinesterase
  13. Creatinine
  14. Electrolytes
    a. Carbon Dioxide/Bicarbonate
    b. Chloride
    c. Potassium
    d. Sodium
  15. Fructosamine
  16. Gamma-Glutamyl Transpeptidase (GGT)
  17. Glucose
  18. High Density Lipoprotein (HDL)
  19. Iron
  20. Lactate Dehydrogenase (LDH)
  21. Magnesium
  22. Phosphorus
  23. Protein
  24. Triglycerides
  25. Uric Acid
  26. Troponin
B. Therapeutic Drug Monitoring (TDM)
  1. Overview
  2. Carbamazepine
  3. Digoxin
  4. Gentamicin
  5. Lidocaine
  6. Lithium
  7. Phenytoin/Dilantin
  8. Procainamide
  9. Quinidine
  10. Theophylline
  11. Valproic Acid
  C. Endocrine Function Tests
  1. Cortisol
  2. Follicle-Stimulating Hormone (FSH)
   3. Gastrin
  4. Human Chorionic Gonadotropin (HCG)
  5. LH
  6. Prolactin
  7. T3
  8. T3 Uptake
  9. Free T3
  10. Thyroxine (T4)
  11. Free T4
  12. TBG
  13. TSH
D. Tumor Markers And Special Chemistry Tests
  1. Alpha-Fetoprotein (AFP)
  2. Carcinoembrionic Antigen (CEA)
  3. Ferritin
  4. Follate/Folic Acid
  5. Occult Blood
  6. Prostatic Acid Phosphatase (PAP)
  7. Prostate-Specific Antigen (PSA)
  8. Vitamin B-12
E. Immunoprotein Tests
  1. Complement
    a. C3
    b. C4
  2. CRP
  3. Immunoglobulins (IgA, IgE, IgG, IgM)
  4. Protein Electrophoresis
F. Drugs of Abuse
  1. Overview
  2. Test Methodologies
  3. Amphetamines
  4. Barbiturates
  5. Benzodiazepines
  6. Cannabinoids/Marijuana
  7. Cocaine
  8. Lysergic Acid Diethylamide (LSD)
  9. Methadone
  10. Methaqualone
  11. Opiates
  12. Phencyclidine
G. Instrumentation Review
  Abaxis Piccolo
  Abaxis Piccolo Xpress
  Abbott AxSYM
  Abbott Architect c4000
  Abbott Architect i2000 Series
  Abbott Architect ci8200 System
  Abbott i-STAT
  Alfa Wassermann ACE Alera
  AMS Liasys
  Awareness Technologies ChemWell
  Awareness Technology STAT FAX 4500
  Beckman Coulter Unicel Series
  Beckman Coulter Access
  Binding Site ESP600
  bioMerieux Mini Vidas
  Carolina Chemistries BioLis 24i
  DiaSorin Liaison
  Grifols Triturus
  Horiba ABX Pentra 400
  Inverness DS2
  J&J DT System
  J&J Vitros ECi/ECiO
  J&J Vitros 3600
  J&J Vitros 5600
  Medica EasyRA
  Nova Biomedical Critical Care Xpress
  Olympus AU480
  Olympus AU5400
  Olympus AU53000i
  Olympus AU2700
  Polymedco Poly-Chem
  Polymedco Spotchem EZ
  Randox RX Daytona
  Randox RX Imola
  Roche Modular Analytics
  Roche Cobas Integra 400
  Roche Cobas Integra 400 Plus
  Roche Elecsys
  Roche Cobas c311
  Roche Cardiac 200
  Siemens ADVIA Centaur
  Siemens Dimension
  Siemens Dimension RxL Max
  Siemens Dimension Vista 500
  Siemens Immulite
  Siemens Stratus
  Tosoh AIA-Series
  Vital Diagnostics ATAC 8000
  Vital Diagnostics Envoy 500
H. Major In Vitro Diagnostic Technologies
And Their Potential Applications
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
    a. Technological Principle
    b. Radioimmunoassays (RIA)
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Immunofiltration
      Dot Immunobinding Assays
      Capillary Immunoassays
      Particle-Membrane Capture Immunoassays
      Enzyme Amplification
      CEDIA
      Electrochemical Immunoassays
    d. Fluorescent Immunoassays
      Fluorescence Polarization
      Time-Resolved Pulse Fluorescence
    e. Luminescence
      Chemiluminescence
      Bioluminescence
    f. Latex Agglutination
    g. Immunoprecipitation
    h. Affinity Chromatography Immunoassays
    i. Liposome Flow-Injection Immunoassays
  3. IT and Automation
  4. Dry Chemistry
  5. Biosensors
  6. Robotics
  7. Chemometrics
  8. Molecular Diagnostics
    a. Sample Preparation
    b. Hybridization
    c. Separation
    d. Detection/Measurement
Test Formats
  a. Filter Hybridization
  b. Southern Blot
  c. Northern Blot
  d. In Situ Hybridization
  e. Others
Labeling Techniques
Amplification Methods
   Polymerase Chain Reaction
    Temperature Cyclers
    PCR Variations
      Immuno-PCR
      QC-PCR.
      DAP-PCR
  Strand Displacement Activation
  TMA
   Ligase Chain Reaction
  Branched DNA
    Hybridization Protection Assay
  Nucleic-Acid Sequence-Based Amplification
  Self-Sustained Sequence Replicase
  Others
    Ampliprobe
    CAR
    CAS
    CPT
    Dendritic Polymer Technology
    ISO-CR
    LAT
    Probe Networks
    RAMP
    Repair Chain Reaction
    Rolling Circles
    Sequence Independent Gene Amplification
    Sequence Initiation Reaction
    SISPA
    Solid Phase Amplification
Detection Technologies
  a. Radioactive Methods
    Overview
    Major Isotopes
      P-32
      S-35
      H-3
      I-125
  b. Non-Isotopic Methods
    Enzymatic Labels
    Chemical Labeling
      Indirect Chemical Labeling
      Direct Chemical Labeling
    Fluorescence
    Chemiluminescence
    Electrical Conductivity
Instrumentation Review
  a. Abbott LCx
  b. Beckman Coulter/Biomek FK
  c. Becton Dickinson SDA
  d. Bio-Rad GeneScope
  e. Gen-Probe Tigris
  f. Roche Cobas Amplicor
  g. Tecan LS Series
Biochips: Genosensors, Microarrays, and Labs-on-the-chip
    Liquid Transportation and Mixing
    Separation
    Reaction
    Detection

Worldwide Market Overview
  1. Business Environment
  2. Market Structure
  3. Market Size and Growth

U.S.A.
A. Executive Summary
B. Business Environment
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Industry Consolidation
  4. Managed Care
  5. Hospitals
  6. Admissions
  7. Length of Stay
  8. Industry Diversification
  9. Physician Demographics
  10. Population Aging
    a. Chronic Illness
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
  11. Laboratory Regulations
C. Market Structure
  1. Centralized Testing
    a. Hospitals
    b. Commercial/Private Laboratories
  2. Decentralized Testing
    a. Physician Offices/Group Practices
    b. Point-of-Care Testing
    c. Home/Self Testing
    d. Other Decentralized Testing Locations
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales, and Market Shares

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized

Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

Competitive Assessments
Abbott Laboratories
AdnaGen
Ambrilia
AMDL
Beckman Coulter
Biomedical Diagnostics
BioMerieux
Bio-Rad
Canag Diagnostics
Dako
DiaSorin
Eiken
Fujirebio
Instrumentation Laboratory
J&J
Kyowa Medex
Matritech
Roche
Siemens
Sysmex
Thermo Fisher
Trinity Biotech
Tosoh
Wako
Wallac

List of Tables

More new market research reports by the publisher can be found at Venture Planning Group page.

 

CONTACTS

The Market Publishers, Ltd.

Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970

ps@marketpublishers.com

MarketPublishers.com